Clinical Trials
63 trialsPeople's Hospital of Xinjiang Uygur Autonomous Region
People's Hospital of Xinjiang Uygur Autonomous Region
MYELAXAT
University Hospital, Grenoble
CARAVAGGIO
Fadoi Foundation, Italy
Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer
LEO Pharma
Evaluating the Risk of Postoperative Venous Thromboembolism in Cervical Cancer Patients
Chongqing University Cancer Hospital
AIRPORT-MPN
Ottawa Hospital Research Institute
CONTEST
University of Aarhus
ROSIE
Radboud University Medical Center
Risk Factors of Venous Thromboembolism After Colorectal Cancer Surgery
Pirogov Russian National Research Medical University
Cancer Associated Thrombosis : What is the Proportion of Patients Ineligible to a Study as CARAVAGGIO
Centre Hospitalier Universitaire de Saint Etienne
CANVAS
Alliance Foundation Trials, LLC.
APEX
Alexion Pharmaceuticals, Inc.
THRIMM
University Medical Center Groningen
H2H-OSCAR-US
Bayer
Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant Chemotherapy
Duke University
A Study of Special Use Results Surveillance of Revlimid 5mg Capsules
Celgene
A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of Use
Celgene
Improved Adherence With Extended Venous Thromboembolism Prophylaxis After Major Cancer Surgery
McMaster University
Tumor-educated Platelets in Venous Thromboembolism
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
PRACTISE
Bayer
Incidence of Venous Thromboembolism in Patients Undergoing Major Esophageal Resection
McMaster University
Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism
Academic and Community Cancer Research United
HEMOBREAST
University Hospital, Geneva
Oral Apixaban (Eliquis) Versus Enoxaparin (Lovenox) for Thromboprophylaxis in Women With Suspected Pelvic Malignancy
University of Colorado, Denver
VENETIA
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Venous Thromboembolism in Advanced Gastric Cancer Patients
Asan Medical Center
Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma
Dana-Farber Cancer Institute
PREDICARE
LEO Pharma
A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants
Janssen Research & Development, LLC
Thromboprophylaxis After Surgery for Gynecologic Malignancy in China
Huazhong University of Science and Technology
Anti-Platelet and Statin Therapy to Prevent Cancer-Associated Thrombosis
Case Comprehensive Cancer Center
Fragmin for the Treatment of Acute VTE in Pediatric Cancer Patients
Pfizer
Cancer Venous Thromboembolism (VTE)
Daiichi Sankyo
AVERT
Ottawa Hospital Research Institute
Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery
McMaster University
Characterizing Recurrent Thromboembolism, Major Bleeding and All-Cause Death in Patients With Cancer-Associated Thromboembolism Treated With Rivaroxaban
Bayer
CASTA-DIVA
Assistance Publique - Hôpitaux de Paris
DISOLVE
University of Vermont
PENELOPE Observational Study: Prophylaxis and Treatment of Arterial and Venous Thromboembolism
Gruppo Italiano Malattie EMatologiche dell'Adulto
Prescription and Utilization of Low Molecular Weight Heparin in Usual Medical Practice for the Curative Treatment of Venous Thromboembolism in Patients With Cancer
LEO Pharma
ACT
Thomas Jefferson University
A Comparative Study of Prophylactic Anticoagulation in Meningioma Surgery
St. Olavs Hospital
Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery
GlaxoSmithKline
REMARK
Ottawa Hospital Research Institute
Time of Treatment With LMWH in Cancer Patients With Thromboembolic Disease
Delos Clinical
The Roles of Tissue Factor in Malignant Gliomas
Ontario Clinical Oncology Group (OCOG)
Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients
M.D. Anderson Cancer Center
A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors
Altor BioScience
SOME
Ottawa Hospital Research Institute
CARMEN
Floralis